Literature DB >> 10986624

The treatment of osteoporosis. Antiresorptive therapy.

P D Miller1.   

Abstract

Antiresorptive pharmacologic interventions for the prevention and treatment of osteoporosis are discussed. These interventions include estrogen; calcitonin; biphosphonates; and selective estrogen receptor modulators and their use in postmenopausal osteoporosis, steroid-induced osteoporosis, and osteoporosis in men. The effects of antiresorptive therapy on bone mineral density, biomarkers of bone turnover, and fracture risk are discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10986624

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

2.  Femur ultrasound (FemUS)--first clinical results on hip fracture discrimination and estimation of femoral BMD.

Authors:  R Barkmann; S Dencks; P Laugier; F Padilla; K Brixen; J Ryg; A Seekamp; L Mahlke; A Bremer; M Heller; C C Glüer
Journal:  Osteoporos Int       Date:  2009-08-20       Impact factor: 4.507
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.